Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Julphar
Queensland Health
Medtronic
QuintilesIMS
Moodys
McKesson
McKinsey
US Army

Generated: December 15, 2018

DrugPatentWatch Database Preview

Drug Sales Trends for AMPHET/DEXTR

« Back to Dashboard

Payment Methods and Pharmacy Types for AMPHET/DEXTR (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $27,089,727
INSIDE ANOTHER STORE $197,771,885
[disabled in preview] $437,865,299
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 279,885
INSIDE ANOTHER STORE 3,986,672
[disabled in preview] 7,289,989
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $70,062,329
MEDICARE $65,294,918
[disabled in preview] $537,984,801
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for AMPHET/DEXTR
Drug Units Sold Trends for AMPHET/DEXTR

Annual Sales Revenues and Units Sold for AMPHET/DEXTR

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
AMPHET/DEXTR ➤ Try a Free Trial ➤ Try a Free Trial 2016
AMPHET/DEXTR ➤ Try a Free Trial ➤ Try a Free Trial 2015
AMPHET/DEXTR ➤ Try a Free Trial ➤ Try a Free Trial 2014
AMPHET/DEXTR ➤ Try a Free Trial ➤ Try a Free Trial 2013
AMPHET/DEXTR ➤ Try a Free Trial ➤ Try a Free Trial 2012
AMPHET/DEXTR ➤ Try a Free Trial ➤ Try a Free Trial 2011
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Deloitte
Johnson and Johnson
Daiichi Sankyo
Merck
Fish and Richardson
Express Scripts
AstraZeneca
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.